Regional cerebral blood flow changes in chronic alcoholic patients induced by naltrexone challenge during detoxification

Journal of Nuclear Medicine

Volumn 40, Issue 1, 1999, Pages 19-24

  Catafau, Ana M ^a   Etcheberrigaray, Alvaro ^b   Perez De Los Cobos, José ^b   Estorch, Montserrat ^b   Guardia, Josep ^b   Flotats, Albert ^b   Bernà, Lluís ^b   Marí, Carina ^b   Casas, Miquel ^b   Carrió, Ignasi ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NONE

Author keywords

Alcoholism; Naltrexone; Regional cerebral blood flow; SPECT

Indexed keywords

CARFENTANIL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; NALTREXONE; OPIATE ANTAGONIST;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OBSERVER VARIATION; OBSESSION; ORBITAL CORTEX; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; STRUCTURE ANALYSIS;

ADULT; ALCOHOLISM; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TEMPERANCE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032923289     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Volpicelli JR, Alterman AI, Hayasida M, O'Brien ChP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876-880.
2. Edwards G, Gross MM. Alcohol dependence: provisional description of a clinical syndrome. BMJ. 1976;1:1058-1061.
3. O'Malley SS, Jaffe AJ, Chang G, et al. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry. 1996;53:217-224.
4. Reid LD. Endogenous opioids and alcohol dependence: opioid alkaloids and the propensity to drink alcoholic beverages. Alcohol. 1996;13:5-11.
5. Van Ree JM. Endorphins and experimental addiction. Alcohol. 1996;13:25-30.
6. Gianoulakis C, De Waele JP, Thavundayil J. Implication of the endogenous opioid system in excessive ethanol consumption. Alcohol. 1996;13:19-23.
7. Woods SW, Koster K, Krystal JK, et al. Yohimbine alters regional cerebral blood flow in panic disorder. Lancet. 1988;11:678
8. Hoehn-Saric R, Pearlson GD, Harris GJ, Machlin SR, Camargo EE. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry. 1991;148:1243-1245.
9. De Cristofaro MTR, Sessarego A, Pupi A, Biondi F, Faravelli C. Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study. Biol Psychiatry. 1993;33:505-512.
10. Burt RW, Witt RM, Cikrit DF, Reddy RV. Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT. Radiology. 1992;182:461-466.
11. O'Brien ChP. Opioids. Antagonists and partial agonists. In: Galanter M, Kleber HD. eds. The American Psychiatric Press Textbook of Substance Abuse Treatment, 1st ed. Washington, DC: American Psychiatric Press: 1994:223-236.
12. 99mTc-HMPAO SPECT study. Eur J Nucl Med. 1996;23:1329-1337.
13. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974;20:1255-1270.
14. 99mTc-HMPAO-related changes in visual cortex can be detected with a single-head SPET system. Nucl Med Commun. 1996;17:480-484.
15. Nicolas JM, Catafau AM, Estruch R, et al. Regional cerebral blood flow SPECT in chronic alcoholism: relation to neuropsychological testing. J Nucl Med. 1993;34: 1452-1459.
16. Volkow ND, Wang GJ, Hitzemann R, et al. Recovery of brain glucose metabolism in detoxified alcoholics. Am J Psychiatry. 1994;151:178-183.
17. Kuruoglu AC, Arikan Z, Vural G, Karatas M, Arac M, Isik E. Single photon emission computed tomography in chronic alcoholism. Antisocial personality disorder may be associated with decreased frontal perfusion. Br J Psychiatry. 1996;169:348-354.
18. Meyer MC, Straughn AB, Lo M-W, et al. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration. J Clin Psychiatry. 1984;45:15-19.
19. O'Brien CP, Greenstein R, Mintz J, et al. Clinical experience with naltrexone. Am J Drug Alcohol Abuse. 1975;2:365-377.
20. Myung CL, Wagner HN Jr, Tanada S, Frost JJ, Bice AN, Dannals RF. Duration of occupancy of opiate receptors by naltrexone. J Nucl Med. 1988;29:1207-1211.
21. Van Dyck CH, Rosen MI, Thomas M, et al. SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine. Psychiatr Res Neuroimaging. 1994;55:181-191.
22. Krystal JH, Woods SW, Kosten TR, et al. Opiate dependence and withdrawal: preliminary assessment using single photon emission computed tomography (SPECT). Am J Drug Alcohol Abuse. 1995;21:47-63.
23. Tiihonen J, Kuikka J, Hakola P, et al. Acute ethanol-induced changes in cerebral blood-flow. Am J Psychiatry. 1994;151:1505-1508.
24. Geary WA II, Wooten GF. Dose effects of naloxone on fixed morphine dependence: simultaneous behavioral and 2-deoxyglucose in the rat. Brain Res. 1985;332:69-78.
25. Fanelli RJ, Walovitch RC, Jasinski DR, London ED. Naloxone fails to alter local cerebral glucose utilization in the rat. Pharmacol Biochem Behav. 1988;31:481-485.
26. Frost JJ, Wagner HN Jr, Dannals RF, et al. Imaging opiate receptors in the human brain by positron tomography. J Comput Assist Tomogr. 1985;9:231-236.
27. Grant S, London ED, Newlin DB, et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA. 1996;93:12040-12045.
28. Zubieta JK, Gorelik DA, Stauffer R, Ravert HT, Dannals RF, Frost JJ. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med. 1996;2:1225-1229.
29. Modell JG, Glaser FB, Cyr L, Mountz JM. Obsessive and compulsive characteristics of craving for alcohol in alcohol abuse and dependence. Alcohol Clin Exp Res. 1992;16:272-274.
30. Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlek K, Sykor K. The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther. 1987;41:266-274.
31. Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale. A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry. 1996;53:225-231.
32. Rapoport JL. Obsessive compulsive disorder and basal ganglia dysfunction. Psychol Med. 1990;20:465-169.
33. Modell JG, Mountz JM. Focal cerebral blood flow change during craving for alcohol measured by SPECT. J Neuropsychiatry Clin Neurosci. 1995;7: 15-22.
34. Volkow ND, Gillespie H, Mullani N, et al. Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatr Res Neuroimaging. 1996;67:29-38.
35. Rubin RT, Villanueva-Meyer J, Ananth J, Trajmar PG, Mena I. Regional xenon-133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Arch Gen Psychiatry. 1992;49:695-702.